Table 2a.
Controls | Schizophrenia Patients | |||
---|---|---|---|---|
Target ROI | Placebo | Nicotine | Placebo | Nicotine |
Left IFG | 0 (0.023) | −0.015 (0.023) | −0.075 (0.025) | 0.045 (0.026) |
Right IFG | 0.055 (0.020) | 0.028 (0.035) | −0.033 (0.028) | 0.038 (0.043) |
Controls | Schizophrenia Patients | |||
---|---|---|---|---|
Target ROI | Placebo | Nicotine | Placebo | Nicotine |
Left IFG | 0 (0.023) | −0.015 (0.023) | −0.075 (0.025) | 0.045 (0.026) |
Right IFG | 0.055 (0.020) | 0.028 (0.035) | −0.033 (0.028) | 0.038 (0.043) |